Nighan Warren JR 4

What Happened
Warren Nighan Jr., Senior VP of Quality and Regulatory at AngioDynamics (ANGO), had performance share units vest on July 22, 2026. 5,694 shares of common stock were issued to him upon settlement of the earned PSUs. To satisfy tax withholding obligations, 1,671 of those shares were withheld/sold at $13.82 per share for a tax payment of $23,093. The original target grant was 20,052 PSUs; the remainder were forfeited.

Key Details

• Transaction date: July 22, 2026; Form 4 filed July 24, 2026 (timely filing).
• Issued/Acquired: 5,694 shares via vesting/settlement of PSUs (reported as derivative exercise/settlement, $0 acquisition price for award).
• Tax withholding: 1,671 shares surrendered/ disposed at $13.82 per share to satisfy tax liability = $23,093. (Transaction code F = tax withholding)
• Forfeiture/cancellation: 14,358 of the original 20,052 target PSUs were not earned and were forfeited/cancelled (per footnote).
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnotes: PSUs were granted July 19, 2023 with performance metrics over fiscal 2024–2026; up to 200% of target could be earned; 20% of earned shares subject to TSR modifier vs peers.

Context
This was a standard settlement of performance-based equity rather than an open-market purchase or discretionary sale. The withholding of shares to cover taxes is routine and does not, by itself, indicate a buy/sell signal. The filing shows earned PSUs converted to shares and the unearned portion cancelled per the plan metrics.